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1. Introduction
Nucleic acids, which are well-known 
genetic information carriers, play an 
essential role in transcription and trans-
lation.[1] Pioneering work by Seeman led 
to a new line of “structural DNA nano-
technology” research based on the highly 
specific Watson–Crick base pairing capa-
bility, which confers powerful properties 
to nucleic acids that include desirable 
biocompatibility, high predictability, and 
nanoscale controllability.[2,3] Nucleic acids 
are considered as one of the most program-
mable materials for the “bottom-to-up” 
construction of 2D and 3D nanostructures 
of various sizes and shapes,[4] such as 
junctions, lattices, double crossovers, and 
DNA origami.[5] In the past few decades, 
nucleic acids have been investigated in 
“dynamic DNA nanotechnology” instead 
of depending on the simple phosphate-
sugar backbone. Dynamic DNA nanotech-
nology includes the dynamic displacement 
and movement of nanostructures stim-
ulated with the transitions of nucleic 
acids,[6] such as DNA tweezers,[7,8] DNA walkers,[9,10] DNA 
dendrimers,[11] and DNA circuits.[12] Among them, toehold-
mediated strand displacement (TMSD), which is powered by 
the free energy of strand displacement, is a typical example. 
TMSD is triggered by a complementary single-stranded domain 
called the toehold. Nucleic acid strands with a certain degree 
of complementarity hybridize with each other, displacing one 
or more prehybridized nucleic acid strands. The kinetics of 
TMSD are largely dependent on the sequence and length of the 
toehold. In theory, the rate of the strand-displacement reaction 
of TMSD can be quantitatively controlled over 106-fold.[13,14]
Among TMSD reactions, catalytic hairpin assembly (CHA), 
was originally introduced by Yin et al.[15] and engineered for mul-
tiple analytical applications by Li et al.,[16] is an enzyme-free, high-
efficiency, and isothermal amplification method. A typical CHA 
reaction is executed using two complementary DNA strands pre-
pared as stable hairpin structures. Thus, spontaneous interaction 
between the two DNA strands is kinetically blocked, as the com-
plementary domains are caged within the hairpin stems. With 
single-stranded nucleic acids, the two hairpins are opened suc-
cessively because of the toehold nature, and the most thermody-
namically favorable DNA duplexes are quickly formed.[17]
Normally, the isothermal nucleic acid amplification techno-
logies including enzyme-assisted amplification method and 
Nucleic acids are considered as perfect programmable materials for cascade 
signal amplification and not merely as genetic information carriers. Among 
them, catalytic hairpin assembly (CHA), an enzyme-free, high-efficiency, 
and isothermal amplification method, is a typical example. A typical CHA 
reaction is initiated by single-stranded analytes, and substrate hairpins are 
successively opened, resulting in thermodynamically stable duplexes. CHA 
circuits, which were first proposed in 2008, present dozens of systems today. 
Through in-depth research on mechanisms, the CHA circuits have been 
continuously enriched with diverse reaction systems and improved analytical 
performance. After a short time, the CHA reaction can realize exponential 
amplification under isothermal conditions. Under certain conditions, 
the CHA reaction can even achieve 600 000-fold signal amplification. 
Owing to its promising versatility, CHA is able to be applied for analysis 
of various markers in vitro and in living cells. Also, CHA is integrated with 
nanomaterials and other molecular biotechnologies to produce diverse 
readouts. Herein, the varied CHA mechanisms, hairpin designs, and reaction 
conditions are introduced in detail. Additionally, biosensors based on CHA 
are presented. Finally, challenges and the outlook of CHA development are 
considered.
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enzyme-free amplification method are easy to realize high 
sensitivity. But the enzyme-assisted amplification method, 
such as rolling circle amplification (RCA), strand displacement 
amplification (SDA), loop-mediated isothermal amplification 
(LAMP), has the shortcomings of high cost, storage difficulty, 
and complicated reaction conditions. In comparison to other 
enzyme-free amplification method, including hybridization 
chain reaction (HCR), DNAzyme, and entropy driven circuit 
(EDC), CHA endows with higher catalytic efficiency, lower back-
ground signals, simpler and more stable reaction system.[2,18,19] 
As a simple, yet versatile isothermal nucleic acid amplifica-
tion strategy, CHA has emerged as a satisfactory alternative 
for biomarker determination. Studies show that CHA can be 
adapted to multiple analytical formats, such as fluorescent,[20] 
electrochemical,[21] colorimetric,[22] surface plasmon resonance 
(SPR),[23] and electrophoretic methods.[24] Studies also indicate 
that CHA can be easily and rationally integrated with other 
isothermal amplification reactions under various conditions 
(different temperatures, buffers, and enzymes) to improve the 
sensitivity and specificity of assays.[25] Although the entity of 
CHA is nucleic acid strand displacement, the detection targets 
are not confined to nucleic acids. Many other analytes including 
metal ions,[26] proteins,[27] enzymes,[28] and even cancer cells[29] 
have been measured based on CHA.
Numerous studies related to CHA have been published over 
the past decades. In this review, we provide a map of the CHA 
landscape. First, we describe the mechanism, development, 
kinetics characterization of CHA, and the analytical techniques 
for CHA products. Furthermore, we summarize the biosensing 
applications of CHA. Finally, the challenges and outlook of 
CHA development are considered.
2. Characterization and Development of CHA
2.1. Mechanism of Typical CHA
CHA, a programmable DNA circuit, was first proposed by 
Yin et al. in 2008.[15] These authors attempted to engineer nucleic 
acid sequences to execute dynamic functions. As shown in 
Figure 1A, CHA is achieved using two partially complementary 
DNA hairpins (H1 and H2) and one single-stranded oligonu-
cleotide (I) in three steps. Both hairpins are composed of three 
continuous domains, and each domain contains a toehold. 
First, I initiates the allosteric transition of H1 by specifically 
interacting with the exposed toehold H1. The intermediate 
product H1/I complex is thus formed. Similarly, the subse-
quently exposed toehold of H1 initiates another assembly 
reaction with H2. H2 is thus opened, and the unstable complex 
H1/I/H2 is generated. Then, the newly released H2 triggers 
branch migration, and I is dissociated from H1. Such circular 
DNA assembly–assembly–disassembly reactions yield 100-fold 
amplified H1/H2 duplexes within a short time. Nonspecific 
reactions between hairpins are prevented because the comple-
mentary sequences are trapped within a secondary structure. 
Because of the inherent modular and scalable characteristics, 
the two main features of CHA on signal amplification are 
enzyme-free and isothermal. Using the same principle, four 
kinds of circuits were designed as follows: catalytic formation 
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of branched junctions (three-arm and four-arm), autocatalytic 
duplexes formation by cross-catalytic circuits, nucleated den-
dritic growth of a binary molecular “tree,” and autonomous 
locomotion of the bipedal walker.
The kinetic analysis data reported by Yin indicate that 3.5% 
of A and B spontaneously hybridize without an initiator.[15] 
The high background values would greatly counteract the diag-
nostic applications of CHA. Various factors may contribute 
to the leakage, including the impurities of reactants and 
toehold-independent reactions. The key reaction in CHA is 
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Figure 1. Mechanisms of diverse CHA systems. A) Typical CHA circuit.[16] B) Cross-CHA.[15] C) Self-replicating CHA.[36] D) Two-layer CHA.[37] E) Dual 
CHA.[38] F) Branched CHA.[15] G) Localized CHA circuit.[42]
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the design and preparation of DNA sequences with functional 
domains and specific hairpin structures. The DNA sequences 
are designed according to the target structures, and the DNA 
strands form the prescribed structures through self-assembly. 
Undesirable DNA sequences and inappropriate reaction condi-
tions result in unsatisfactory or unstable secondary structures. 
Even if the hairpins are perfectly designed and formed, the 
hairpin stems can “breathe” inadvertently, revealing the toehold 
domains that initiate the strand displacement reactions. In 
the kinetics curves, a fast signal increase is observed until 
the impure reactants are depleted in cases in which leakage 
is induced by impurities. A steady signal increase is observed 
until the substrates are used up in cases of toehold-independent 
leakage.[16]
2.2. Diversification of CHA
Regarding the analytical applications of CHA, the effective 
control of background signals is the foremost problem. Many 
researchers have attempted to solve this problem. Li et al. dis-
sected the DNA sequence designed by Yin, and improved 
the CHA circuit by optimizing the domain organization and 
sequence (Figure 1B).[16] First, they found that several “clamp” 
domains designed to avoid uncatalyzed reactions in the original 
hairpins play a weak role in reducing the background. There-
fore, they simplified the hairpins sequences by eliminating 
these domains. Because of dimerization, the hairpin loops were 
optimized without complementary sequences to the overhangs. 
Second, they hypothesized that proper lengths of the domains 
guarantee the sensitivity and specificity of CHA regarding 
kinetics and thermodynamic considerations. This view is widely 
held, as many researchers have determined the signal-to-noise 
ratio of CHA circuits to select the optimal toehold lengths.[30–32] 
The simplified CHA circuit was introduced to construct various 
biosensors. Nuclease contamination is common in the labora-
tory, and most nucleases require Mg2+ or other ions to func-
tion. In addition, nonspecific reactions are largely prevented 
in the absence of Mg2+. For this reason, researchers identi-
fied an improved CHA reaction buffer named TNaK buffer 
(20 × 10−3  m Tris, pH 7.5; 140 × 10−3 m NaCl; 5 × 10−3  m KCl), 
which led to the CHA circuit achieving nearly a zero background 
(<0.5 m−1 s−1) and a good turnover rate (>1 min−1). Meanwhile, 
CHA was adapted to determine nucleic acid and non-nucleic 
acid analytes through multiple analytical readouts. This work 
has significantly improved the performance of the CHA reac-
tion and greatly promoted biosensor research based on CHA.
Ellington et al.[33] considered blocking the inadvertent 
binding reaction or its continuations driven strand exchange 
reactions to prevent uncatalyzed strand exchange reactions. 
They considered this as a simple way to introduce mismatched 
base-pairs for developing mismatched CHA (MismatCHA) 
circuits. According to the source of leakage, both original hair-
pins introduce single or double mismatches into different 
domains (ends of helices or adjacent to the loop) to perform 
MismatCHA reactions. The collected fluorescent signal showed 
that the mismatched variants decrease the background, and 
CHA reactions are compromised to varying degrees. Generally, 
MismatCHA reactions yield higher signal-to-background ratios 
than the typical CHA reactions. In addition, various biosensors 
have been developed based on MismatCHA.[34] These strategies 
achieve higher sensitivity, a broader linear range, and better 
specificity and reproducibility than matched CHA. Simultane-
ously, these methods possess excellent performance for the 
analysis of cell extracts and serum specimens.
Several double and multiple CHA reactions have been 
developed for practical applications. Earlier in this article, we 
mentioned that Yin developed cross-catalytic hairpin assembly 
(cross-CHA) (Figure 1B).[15] Four hairpin species (H1, H2, H3, 
and H4) are involved in this system. The initiator I triggers the 
first CHA reaction to produce the duplex H1/H2. Then, the 
overhangs of B function as the catalyst that triggers the second 
CHA reaction to form the duplex H3/H4. In turn, the over-
hangs of H4 bind with H1 to circularly trigger the first CHA 
reaction. Hence, in the presence of I, the exponentially autocata-
lytic reaction between H1/H2 and H3/H4 is executed in cycles. 
The system not only shows that autocatalysis and exponential 
system kinetics are driven by the free energy of base-pair for-
mation, but also pave the way for enzyme-free, cascade, and iso-
thermal biosensors. Cross-CHA based biosensors for DNA have 
achieved significantly improved sensitivity and selectivity. Yue 
and co-workers established cross-CHA based assay. The con-
trol experiments clearly show that the sensitivity of cross-CHA 
(10 × 10−12 m) is improved 100-fold in comparison with that 
of traditional CHA (1 × 10−9 m). Different initiators with one-
base mismatched, completely mismatched, and perfectly com-
plementary were respectively introduced into the cross-CHA 
system. The signal of complementary initiator was significantly 
increased, whereas the signals of both mismatched initiators 
is negligible.[35] Interestingly, two hairpin substrates have also 
been engineered to complete double CHA reactions.[36] This 
system is named self-replicating catalyzed hairpin assembly 
(SRCHA). In this system, the complementary domains are still 
blocked in the stems of hairpins, but the two contrived split 
initiator sequences are designed in two hairpins. Two sub-
strates can coexist stably. However, in the presence of catalytes, 
the CHA reaction is triggered, and duplexes are formed. Thus, 
the two split initiator sequences are close and trigger the CHA 
reaction (Figure 1C). The spontaneous, self-catalyzed, and cyclic 
CHA circuit is achieved. Based on cascade signal amplification, 
SRCHA has been applied for the determination of nucleic acids 
and other small molecules. Ellington et al. researched multi-
layer CHA for further improving amplification (Figure 1D).[19,37] 
Compared with the cross-catalytic hairpin assembly, the stage at 
which the duplex of the second CHA circularly triggers the first 
CHA reaction does not exist in two-layer CHA. They focused 
on the origins, outcomes, and characteristics of leakage in mul-
tiple CHA reactions, and finally achieved high quality two-layer 
CHA circuits that exhibit the lowest leakage and yield 7000-fold 
signal amplification. Thereafter, they successfully devised a 
four-layer CHA reaction that showed a record-high 600 000-fold 
signal amplification. However, the turnover rate of the second 
CHA is relatively slow. The overall four-layer CHA reaction 
takes as long as 19 h. Recently, Zhang et al. demonstrated dual 
CHA aiming to establish an electrochemical cytosensor with 
improved analytical performance (Figure 1E).[38] The introduced 
fuel probe is key for dual CHA because it not only hybridizes 
with the capture probe to decrease the background owing to 
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“breathe”, but also efficiently initiates the second CHA. The 
cytosensor has a detection limit of 30 cells mL−1 within 1.5 h. 
As expected, the sensor also performs well in real samples with 
spiked cancer cells. This work has provided a platform with a 
wide detection range, high sensitivity, high selectivity, and low 
matrix effect for diagnostic applications.
The concept of catalytic formation of branched junctions was 
established by Yin et al..[15] Catalysts circularly initiate the CHA 
reactions between different amounts of metastable hairpins in 
succession to form branched junctions with different numbers 
of arms (Figure 1F). The rational design of sticky ends can bring 
branched DNA junctions into full play. In addition to the initial 
signal amplification, the sensing platforms based on branched 
DNA junctions show significantly improved sensitivity because 
the ends of every arm can be engineered to form DNAzymes,[39] 
transduce other isothermal amplification methods,[27] and bind 
with nanoparticles[40] to further amplify signals. With additional 
hairpins, the process and final structure are more complicated. 
Hence, the sequence design should be approached with caution.
Recently, another interesting CHA system called localized 
catalytic hairpin assembly (LCHA) has been described.[41,42] 
LCHA is performed in a compact space rather than common 
homogeneous solution because the successive CHA reac-
tants are confined in biocompatible mediums, such as micro-
particles, gold electrodes and DNA nanowires. That is achieved 
via toehold-mediated strand exchange and proximity effect 
(Figure 1G). Initially, the researchers were surprised at that the 
LCHA is incredibly robust in varied conditions and verified the 
potentials of practical application. Thanks to the local high con-
centration of substrates, several advantages have been proved 
in subsequent LCHA based assays. The sensitivity of LCHA 
is obviously increased for the completion time for LCHA was 
5 times shorter than that of CHA, whereas the signal of CHA 
was 1.5 times higher than that of CHA.[43]
The above CHA circuits are finished with DNA. However, 
genetically encoded and transcribed RNA circuits are alter-
natives for reagent production and in vivo function. For this 
reason, a CHA circuit with RNA substrates was developed by 
Bhadra and Ellington[44] Theoretically, RNA possesses the same 
base-paring properties as DNA. The results demonstrated that 
the CHA circuit with RNA substrate functions with similar 
kinetics and sensitivities. It’s interesting that the unpurified 
RNA hairpins transcribed in vitro achieved the CHA reaction as 
well. Based on this, an intracellular RNA imaging method with 
genetically encoded RNA circuit was reported.[45]
We stated the importance of nucleic acid sequence design 
in CHA circuits. For this purpose, the NUPACK (www.nupack.
org), OligoAnalyzer 3.1 (www.Idtdna.com), and Primer Primer 5 
software provide great convenience.[46] On one hand, the 
initial number of nucleotides simulated in diluted solution can 
be obtained. On the other hand, these softwares can analyze 
the structures and parameters of nucleic acid sequences. Thus, 
unintended substrates or undesired structures can be precluded.
2.3. Analytical Techniques of CHA
The diverse CHA circuits bode well for developing biosensors 
for a variety of analytes. Versatile CHA circuits are adopted for 
practical applications in several ways. The CHA circuits can be 
performed alone first, and then coupled with DNAzymes,[30] 
nanoparticles,[47] and biotins[48] to generate signals. In addition, 
CHA circuits can be used for mediating other isothermal ampli-
fication methods to achieve cascade signal amplification.[49]
The CHA system needs to be confirmed before use. Gel elec-
trophoresis techniques, including agarose gel electrophoresis 
(AGE) and polyacrylamide gel electrophoresis (PAGE), are the 
commonly used methods. The positions, amounts, and bright-
ness values of bands enable assessments of the purity of the 
substrates, the presence of nonspecific reactions, catalyzed prod-
ucts, and the reaction efficiency.[50] Even analytes with single 
base mismatched can be distinguished with CHA gel assay.[51] 
In addition, the morphology of CHA products produced with 
novel CHA systems, such as branched junctions,[52,53] train-
shaped nanostructures,[54] nanotetrads[55] and dendrimers,[56] 
is normally imaged directly using atomic force microscopy 
(AFM). The AFM pictures clearly illustrate the shape and size 
of the formed DNA nanostructure.
Multiple analytical readouts applied for CHA based bioanal-
ysis methods are illustrated in Figure 2, including fluorescent,[57] 
chemiluminescent,[35] colorimetric,[58] electrochemical,[59,60] and 
SPR[23] methods. The optical method is the most satisfactory 
and widely used technique for the detection of biomarkers. 
CHA based optical biosensors comprise fluorescence, color-
imetry, chemiluminescence, SPR, and strip sensor techniques. 
With respect to fluorescence, the strategy is divided into four 
types as follows. 1) The fluorescent reporters (fluorophore, 
quantum dot, etc.) are labeled onto the hairpins, which is the 
most simple and direct method. Additionally, the fluorophores 
are separated from the quencher or nano materials (graphene 
oxide, Au) through fluorescence quenching ability to release 
signals.[61–63] This strategy has been employed to develop robust 
and user-friendly strip biosensor for visual, rapid and sensi-
tive detection of microRNAs (miRNA).[64] 2) CHA duplex prod-
ucts specifically hybridize with the DNA reporter complex to 
produce fluorescence. The method decreases the background 
signals.[65] 3) A strategy in which DNAzyme (G-quadruplex, 
ion-dependent DNAzyme) located in the hairpins catalyzes 
fluorescence substrates[66] or hydrolyzes the fluorophore labeled 
strands is popular.[67] 4) For simple biosensors, researchers 
have introduced materials (such as 2-AP) with optical prop-
erties that change with DNA structures into the hairpin 
substrates.[68,69] These CHA based fluorescent methods are not 
confined to quantification. Intracellular imaging and dynamic 
monitoring have also been reported. CHA based colorimetric 
determination methods possess attractive properties, as they 
are enzyme-free, label-free, cost-effective, simple, and practical. 
Initially, these biosensors are obtained through nanoparticles[70] 
or G-quadruplex/hemin DNAzyme[71] with peroxidase-like cata-
lytic activity. Hence, the H2O2-mediated oxidation of substrates 
involving 3,3′,5,5′-tetramethylbenzidine (TMB) and 2,2′-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) is catalyzed 
to achieve naked-eye visualization. Then, DNA-associated Au 
nanoparticle aggregation[72,73] with different colors promotes 
CHA based colorimetric detection approaches. Point-of-care 
testing (POCT) diagnostics are particularly important in emer-
gency circumstances or in low-resource settings. Versatile CHA 
circuits have even been employed to detect biomarkers using 
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the strip biosensing platform. Besides, chemiluminescence and 
SPR have immense potential for quantitatively analyzing the 
CHA system.
Electrochemical methods are also popular for developing CHA 
based biosensors because of their simplicity and sensitivity. Elec-
trochemical signals (current, differential pulse voltammetry) of 
reactants possess electrocatalytic capability for H2O2 or electron 
transfer. Electrochemical biosensors based on CHA are classi-
fied into four types: 1) hairpins synthesized with electroactive 
indicators (toluidine blue, methylene blue, streptavidin-alkaline 
phosphatase); 2) horseradish peroxidases[74] or peroxidase mimics 
(G-quadruplex/hemin complex, PdNPs@Fe-metal organic frame-
works microcrystals)[75,76] formed in the resultant products that 
generate signals; 3) modified nanoparticles (Au nanoparticles, 
Fe3O4/CeO2@Au magnetic nanoparticles, Ag nanoclusters, MoS2 
nanoflowers, Au@Pt nanospheres) covalently bound to CHA 
products to magnify currents;[77–80] and 4) electrochemical indica-
tors (Pb nanoparticles, methylene blue) intercalated into the back-
bone of CHA products to produce signal changes.[81]
3. CHA Based Biosensors for Various Targets
Because of their multiple advantages such as high efficiency, 
easy operation, and great versatility, CHA circuits are broadly 
applied in bioanalysis. This technique not only specifi-
cally recognizes the targets, but also transduces signals with 
100-fold amplification. Owing to the innate character of the 
CHA reaction, CHA is naturally designed for quantitative 
determination of nucleic acids. Because of the significance of 
biomarkers and the application of antibodies, aptamers, and 
DNAzymes, CHA offers promising detection alternatives for a 
wide spectrum of biomarkers. In this section, we summarize 
CHA based biosensing methods for nucleic acids, proteins and 
enzymes, ions, cancer cells, and intracellular imaging.
3.1. Detection of Nucleic Acids
Nucleic acids are widely accepted vital biomarkers for clinical 
diagnosis. CHA based nucleic acid sensors have been developed 
for DNA, messenger RNA (mRNA), and miRNA. And a com-
parison of different CHA strategies for detecting nucleic acids 
is listed in Table 1.
3.1.1. Detection of DNA
According to the mechanism of CHA, single-stranded DNA 
triggers the cascade assembly and disassembly reaction with 
two hairpins. Thus, CHA-mediated DNA sensors constitute 
the most practical use of CHA. Most CHA systems have been 
successfully adapted for establishing DNA analysis strategies, 
such as cross-CHA, SRCHA, and branched DNA junction.
DNA biosensors based on CHA are artificially divided into 
four categories according to the principles of the detection 
Small 2019, 15, 1902989
Figure 2. Various readouts applied for CHA circuits including A) fluorescence,[57] B) colorimetry,[58] C) chemiluminescence,[35] D) surface plasmon 
resonance,[23] and E) electrochemistry.[60]
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system, including pure CHA-mediated DNA biosensors, CHA-
DNAzyme-induced DNA biosensors, CHA-nanoparticle-medi-
ated DNA biosensors, and multiple isothermal amplification 
technique-mediated DNA biosensors.
Initially, bare CHA products hybridize with a fluorophore-
quencher reporter and release fluorescence. The fluorescence 
intensity is proportional to the concentration of the DNA tar-
gets. In addition, the signals can be dynamically monitored.[16] 
Many researchers have attempted to construct a DNA sensing 
strategy by labeling reporters (fluorophore, electroactive indi-
cator) onto the hairpins.[82–84] The corresponding signals can be 
collected by following the progress of the system reaction. The 
analysis of the signals allows the estimation of DNA targets’ 
amounts (Figure 3A).[85]
In addition, G-quadruplex/hemin is greatly favored to be 
combined with nucleic acid circuits. G-quadruplex/hemin 
is easy to control and efficiently catalyzes H2O2-mediated 
oxidation. The G-quadruplex is separated into two hairpins 
with negligible noncatalyzed signals. With target DNA, 
G-quadruplex fragments are close enough and exhibit per-
oxidase-like catalytic activity. These enzyme-free and econo-
mical methods are available for POCT.[86] Interestingly, pro-
graming Mg2+-dependent DNAzyme in the CHA hairpins 
was attempted for DNA determination. DNAzyme subunits 
in an inactive state were introduced into the two hairpins 
separately. Duplex formation led the two subunits to be in 
close proximity. The active Mg2+-dependent DNAzyme recur-
rently cleaves the substrate nucleic acid strands, leading to 
Small 2019, 15, 1902989
Table 1. CHA based assays for nucleic acids.
Target Method Output Reaction time Detection limit Cost Ref.
DNA Pure CHA Electrochemistry 2.5 h 0.39 × 10−15 m Low [83]
DNA Pure CHA Fluorescence 1.5 h 19 × 10−12 m Middle [84]
DNA SRCHA Fluorescence 15 min 58 × 10−12 m Middle [85]
HIV DNA CHA-DNAzyme Colorimetry 19 h 10−17 m Low [86]
DNA CHA-DNAzyme Fluorescence 5 h 0.5 × 10−12 m Low [87]
DNA CHA-nanoparticle Colorimetry 2 h 57.4 × 10−12 m Middle [88]
DNA CHA-nanoparticle Colorimetry 1.5 h 9 × 10−12 m Low [89]
P53 DNA CHA-SDA-DNAzyme Chemiluminescence 4 h 0.85 × 10−15 m High [90]
miR-122 CHA-HCR-DNAzyme Chemiluminescence 2.5 h 0.72 × 10−12 m Middle [92]
miR-21 Pure CHA Electrochemistry 30 min 0.6 × 10−12 m Low [93]
miR-141 CHA-DNAzyme Colorimetry 5 h 0.5 × 10−12 m Low [94]
miR-21 CHA-nanoparticle Fluorescence 1 h 37 × 10−15 m Low [95]
miR-21 CHA-HCR Fluorescence 5 h 2 × 10−12 m Middle [96]
miR-21 Pure CHA Electrochemistry 20 min 30 × 10−15 m Low [97]
miR-21 DNAzyme and 
Nuclease-assisted CHA
Colorimetry 100 min 9.2 × 10−15 m Low [98]
miR-21 CHA gel assay Electrophoresis 1.5 h 10 × 10−15 m Low [51]
Three miRNAs microscopy Fluorescence 15 min 10−17 m High [101]
mRNA RNA CHA Fluorescence 2 h 2.5 × 10−9 m Low [45]
Figure 3. DNA biosensors based on CHA. A) Pure CHA-mediated DNA biosensor.[85] B) CHA-DNAzyme-induced DNA biosensor.[87] C) CHA-nanoparticle-
mediated DNA biosensor.[89] D) Multiple isothermal amplification techniques mediated DNA biosensor.[96]
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the production of fluorescence. And detection limit as low as 
0.5 × 10−12 m was achieved, indicating the efficacy of this 
method (Figure 3B).[87]
At the same time, an increasing number of nanoparticles with 
good biocompatibility and multifunctionality have been devel-
oped, and they have shown good results in bioassays. Graphene/
gold nanoparticles (graphene/Au-NPs) possess peroxidase-
like catalytic activity at the interface. Furthermore, graphene/
Au-NPs present differential catalytic activity when DNA with 
different structures is absorbed onto the surface. For the CHA 
system, hairpins tend to bind to graphene/Au-NPs and inhibit 
their enzyme catalytic activity, whereas CHA products have weak 
binding affinity to graphene/Au-NPs. As a result, in the presence 
of target DNA, the catalytic activity of graphene/Au-NPs is recov-
ered with the formation of CHA duplex products, which catalyze 
the oxidation of TMB to show different colors. This strategy is 
effective for the quantitative and semiquantitative detection of 
DNA.[88] Because of their inherent optical properties, Au-NPs 
have received considerable attention for use as colorimetric bio-
sensors. SsDNA and dsDNA present different adsorption behav-
iors on unmodified Au-NPs. Through van der Waals forces, 
ssDNA is easily adsorbed onto the Au-NPs, which restrains 
salt-induced Au-NP aggregation. Electrostatic repulsion between 
the phosphate backbone and negatively charged Au-NPs has no 
effect on salt-induced Au-NP aggregation. Inspired by the differ-
ential adsorption behaviors and characteristics of CHA, a signal 
amplified but enzyme-free Au-NP-based colorimetric DNA assay 
has been successfully constructed. In the absence of target DNA, 
hairpins are adsorbed onto the Au-NPs, and the solution appears 
pale purple. In the presence of the target, DNA duplexes are 
formed, and the color of the solution changes from pale purple 
to blue. This assay has a low detection limit of 9 × 10−12 m, and 
well distinguishes target DNA from several kinds of nonmatched 
DNA in saliva (Figure 3C).[89]
Many DNA nanotechnologies have emerged for the ampli-
fication of nucleic acids, such as the HCR, LAMP, RCA, DNA 
walker, etc. These technologies have proven to be satisfactory 
options for both amplifying and transducing signals. In the 
same way, these methods are able to be conveniently combined 
to improve the performance of tests. In the early stage, CHA 
was applied for monitoring RCA and SDA reactions.[90] First 
stage reaction products of RCA or SDA initiate the CHA cir-
cuit for dual amplification. This kind of cascade amplification 
system improved the specificity and increased the sensitivity 
by ≈10 000-fold over comparable real-time methods. Under 
isothermal conditions, RCA and SDA amplify the DNA targets 
with polymerase and nicking enzymes. These enzymes may 
require a complex environment. Then, HCR, another typical 
TMSD circuit, is coupled with CHA for bioassay applications. 
Generally, the CHA products are used to trigger HCR. This 
system generates long nicked duplexes, providing additional 
output pathways (Figure 3D).[91] Moreover, the system enables 
intracellular nucleic acid imaging.[92]
3.1.2. Detection of miRNA
miRNAs play an important role in posttranscriptional regula-
tion and serve as circulating biomarkers with great potential 
for diagnosis, therapy, and monitoring. miRNAs are 18–23 nt, 
which remains challenging for determination with traditional 
techniques, while it is great for initiating the CHA reaction. 
miRNA sensors based on CHA account for the largest por-
tion of CHA based biosensors. The miRNAs and DNA share 
similar nucleic acid properties, although miRNAs exist in body 
fluids in low abundance. Generally, the amplification strategies 
for CHA based miRNA biosensors are the same as those for 
DNA biosensors: 1) bare CHA circuits;[93] 2) CHA coupled with 
DNAzyme;[94] 3) CHA combined with nanoparticles;[95] and 
4) the integration of CHA and other isothermal amplification 
methods.[96] Based on these signal amplification approaches, 
CHA circuits are triggered in two ways: miRNAs function 
directly to initiate the reaction, or miRNAs can also be con-
verted into specific DNA sequences involved in hairpin hybridi-
zation. The principles of miRNA-initiated miRNA detection 
methods are analogous to those of DNA detection methods. A 
detailed description of these methods is therefore not necessary 
here. We will focus on introducing different methods for trans-
forming miRNA into DNA.
To construct miRNA detection module and overcome the 
miRNA limitations of instability and degradation, miRNAs were 
equivalently converted into DNA strands. The original idea was 
to design a molecular beacon (MB) as a transducer containing 
the target miRNA complementary domain in the loop and the 
CHA initiator domain in the stem.[17] Once the target miRNA 
binds to the MB, the exposed initiator begins the subsequent 
amplification reaction. Coupling with the strand displacement 
reaction is another approach (Figure 4A).[97] The miRNA hybrid-
izes to the double-stranded DNA probe and displaces the trans-
lator DNA, resulting in hairpins assembly and disassembly.
Researchers have attempted to convert miRNAs into DNA 
to improve sensitivity. This was achieved using four strategies 
as follows. 1) The first was by introducing sequence-dependent 
enzymes, such as duplex-specific nuclease (DSN) (Figure 4B),[98] 
exonuclease III (Exo III),[60] and Klenow fragment-Nb.BbvCI,[25] 
as the MB/miRNA complex can produce numerous translator 
DNAs. Because DSN tends to hydrolyze DNA duplexes with 
more than 10 bp or DNA in DNA/RNA hybrids, Exo III has 
a strong preference for catalyzing blunt or recessed 3′-termini 
of double-stranded DNA, the Klenow fragment possesses 
polymerase activity, and Nb.BbvCI recognizes and cleaves the 
specific domain. 2) Numerous DNA probe-modified magnetic 
NPs and Au NPs have been used for transforming miRNAs.[99] 
The miRNAs hybridized with these DNAs to form a “sand-
wich.” After magnetic separation and dissolution of Au NPs, 
large amounts of translators are released. 3) The combination 
of magnetic NPs and DSN accelerates the collection of trans-
lator DNA.[100] DNA probes modified on magnetic NPs and 
miRNAs are hybridized to form duplexes. Then, DSN cleaves 
the duplexes and releases the translator DNAs, which are 
separated by magnetic fields. 4) A multicomponent nucleic 
acid enzyme (MNAzyme) can be adapted and formed in the 
presence of target miRNAs.[34] Hence, hairpin substrates are 
digested to produce translator DNA. The transformation of 
miRNA to DNA facilitates the collection of low-abundance 
target miRNAs and circularly results in DNA. These techniques 
can be easily extended to multiple miRNA determination 
without redesigning the CHA circuits.
Small 2019, 15, 1902989
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In addition, several unique methods have appeared for miRNA 
quantification. Zhang and co-workers[51] designed three pairs 
of hairpin substrates with different lengths for three miRNA 
species to perform CHA reactions (Figure 4C). The products of 
each CHA reaction migrate to different levels in gel electropho-
resis. The experimental results revealed that the CHA gel assay 
can effectively and simultaneously determine these miRNAs 
at the femtomolar level, and exhibits high discrimination 
capability for miRNA family members and base-mismatched 
miRNAs. Also, the assay can be applied for analyzing miRNAs 
extracted from cell lysates. Li et al used total internal reflection 
fluorescence microscopy (TIRFM) to measure the products 
generated after 15 min of CHA amplification (Figure 4D).[101] 
This method was verified using three miRNAs. Moreover, 
it was applied for directly counting miRNAs in the serum of 
29 volunteers, 18 patients with prostate cancer, and 23 patients 
with breast cancer. Notably, these two assays provide powerful 
and simple tools for multiple miRNA analysis for practical 
application.
3.1.3. Detection of mRNA
mRNA transcribed from target genes carries genetic informa-
tion and guides protein synthesis. Differential mRNA expression 
levels provide vital information for medical diagnosis and 
therapy. However, the quantification and visualization of exceed-
ingly low concentrations of mRNA remain challenging. In light 
of its enzyme-free nature, extraordinary signal amplification 
properties, and isothermal conditions, CHA is widely accepted 
for mRNA determination, especially for intracellular imaging. 
Initially, pure CHA was used for imaging manganese super-
oxide dismutase (MnSOD) mRNA in MDA-MB-231 cells.[102] 
In consideration of the thermostability and nuclease resist-
ance, four locked nucleic acid (LNA) nucleotides are incorpo-
rated into the fluorophore-labeled reporter. The amplification 
effectiveness in buffer is verified first. The CHA system is 
transfected into the cells using lipofectamine. Significant fluo-
rescence is observed for CHA with the LNA-modified reporter, 
whereas a negligible signal is detected for CHA with a regular 
DNA reporter. To further confirm the sensitivity of the CHA 
system, the strategy was used to detect target mRNA in MDA-
MB-231 cells treated with MnSOD, a mRNA inhibitor. The 
CHA reaction with the LNA-modified reporter was capable of 
specifically imaging mRNA in living cells even with low expres-
sion levels. Furthermore, LNA-modified CHA was coupled with 
Au nanorods (AuNRs) to fabricate a mRNA imaging platform. 
AuNRs were functionalized with DNA duplexes labeled with 
fluorophore, and the fluorescence was quenched by AuNRs.[103] 
The introduction of target mRNA initiated the CHA reaction 
after addition of the DNA transfection reagent. The formed 
duplexes hybridized with fluorophore-labeled DNA, and a res-
toration of intracellular fluorescence signal was observed. The 
system showed low cytotoxicity, and endowed high sensitivity 
and specificity.
Most DNA-based CHA circuits are limited by problems asso-
ciated with biological delivery and degradation. However, RNA 
molecules have inherent advantages such as genetic encoding 
Small 2019, 15, 1902989
Figure 4. CHA based miRNA detection assays. A) Equivalent transformation from miRNA to DNA triggers mediated miRNA biosensor.[97] B) Numerous 
DNA triggers converted from miRNA mediated miRNA biosensor.[98] C) Gel assay mediated multiple miRNA biosensor.[51] D) Total internal reflection 
fluorescence microscopy mediated miRNA biosensor.[101]
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and transcription. Genetically encoded CHA is therefore used 
for RNA detection.[45] Hairpins conjugated to part of the fluo-
rescent aptamer and target RNA sequences were separately 
cloned into expression vectors. Two kinds of vectors were 
transformed into the same cell. After cellular transcription, the 
CHA system is ready to perform, and the fluorescent aptamer 
enables function. To avoid redesigning the entire RNA circuit 
each time, a modular system for imaging different RNA targets 
was developed. A genetically encoded RNA-based molecular 
beacon probe was engineered for various RNA detection and 
imaging applications.
3.2. Detection of Proteins and Enzyme Activity
Proteins do not merely supply the right nutrients to the body, 
but are also directly involved in physiological and pathological 
life activities. The levels of proteins are closely associated with 
states and stages of diseases. Accurate proteins analysis plays 
an important role in improving survival rates and treating pain. 
Therefore, it is crucial to measure proteins with high sensitivity, 
significant specificity, and desirable simplicity. Although tradi-
tional immunoassays have achieved great success in protein 
detection, they have certain limitations, such as complicated 
operations, expensive regents and equipment, and unstable 
enzymes. Great efforts have been made to adapt enzyme-free 
nucleic acid isothermal amplification techniques for proteins 
analysis. Among these strategies, CHA is widely accepted for 
detecting proteins including antigens, enzymes, and telomerase. 
And a comparison of different CHA strategies for detecting 
proteins and enzyme activity is listed in Table 2.
3.2.1. Detection of Proteins
CHA is specifically initiated by single-stranded nucleic acids, 
and affinity ligands including antibodies (Abs), aptamers, and 
biotin are required for recognition and transduction of proteins 
into nucleic acid information. Abs are the most commonly used 
recognition elements for proteins. Carcinoembryonic antigen 
(CEA) was used as an example to illustrate Ab-mediated CHA 
circuits for protein detection. First, Abs are modified at the 
ends of two single-stranded DNA molecules (DNA1 and DNA2) 
separately. After the introduction of CEA, the formed sandwich 
complexes DNA1-Ab-CEA-Ab-DNA2 hybridize with hairpin sub-
strates to initiate and accelerate the CHA reaction. Subsequently, 
positively charged Pd NPs are absorbed onto the negative phos-
phate backbone of the duplex products. Then, Pd NPs with high 
catalytic activity produce a significant electrochemical signal. 
This method exhibits excellent analytical performance even in 
serum samples.[104] For an ultrasensitive electrochemical immu-
noassay of CEA, the multi-layer cascade amplification strategy 
(CHA-enzyme digestion-RCA) was adopted (Figure 5A).[105] 
The hybridization of DNA1-Ab-CEA-Ab-DNA2 complexes with 
hairpins leads to degradation by exonuclease III and the release 
of transducer DNA. The transducer DNA binds with another 
hairpin to perform CHA and RCA. Finally, the electroactive 
indicators combine with single-stranded DNA to yield signals. 
This analytical method dramatically improves the analytical 
performance and can detect CEA even at the fg mL−1 level. 
These strategies hold great potential for the determination of 
other biomarkers.
Aptamers, single-stranded oligonucleotides of 15–100 nt, 
bind to targets including proteins, metal ions, bacteria, small 
molecules, exosomes, and even cancer cells with high specificity 
and affinity. Aptamers originate from the systematic evolution 
of ligands by exponential enrichment (SELEX). In contrast to 
Abs, aptamers can be synthesized and controlled easily, and 
they show stability in storage, and are easy to separate. Essen-
tially, aptamers are promising recognition elements for nucleic 
acid circuit-based protein biosensors. CHA based aptasensors 
have been successfully applied for proteins detection, including 
that of CEA, mucin-1, prostate specific antigen (PSA), thrombin, 
and fibronectin. According to the initiating modes of CHA, CHA 
based protein aptasensors can be divided into the following three 
categories: target-induced displacement of the initiator,[106,107] 
target-induced exposure of the initiator,[108] and target-induced 
joint binding-initiating.[109,110] Target-induced displacement of the 
initiator means that an initiator complementary to the aptamer is 
released concomitantly with aptamer–protein binding. As illus-
trated in Figure 5B, the complementary aptamer and initiator 
are modified on magnetic nanoparticles.[111] Upon the addition 
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Table 2. CHA based assays for proteins and enzyme activities.
Target Method Output Reaction time Detection limit Cost Ref.
CEA Proximity induced CHA (Ab) Electrochemistry 100 min 0.43 × 10−15 g mL−1 Middle [104]
CEA Proximity induced CHA-Exo III-RCA(Ab) Electrochemistry 2.5 h 4.2 fg mL−1 High [105]
Thrombin Aptamer-proximity-CHA Fluorescence 100 min 8.3 × 10−12 m Low [106]
CEA CHA-HCR (aptamer) Electrochemistry 5 h 70 ag mL−1 Low [107]
MUC-1 Enzyme-free target recycling and double-output amplification Chemiluminescence 2 h 0.58 fg mL−1 Low [108]
Fibronectin DNA base-stacking using CHA Colorimetry 10 h 2.3 × 10−12 m Low [109]
PSA CHA-aptamer Electrochemistry 3 h 2.3 fg mL−1 Low [111]
CEA CHA-HCR (aptamer) Fluorescence 4 h 0.3 pg mL−1 Low [112]
Avidin CHA-DNAzyme Fluorescence 2 h 2 × 10−12 m Low [87]
RNase H CHA Fluorescence 10 min 0.037 U mL−1 Low [115]
Telomerase CHA-Au Colorimetry 70 min 15 cells Low [28]
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of target proteins, the aptamer specifically binds to the target, 
resulting in the release of the initiator. Hence, CHA amplifica-
tion and signal output can be observed. Target-induced exposure 
of the initiator consists of the exposure of the initiator caged in 
hairpins or duplexes to trigger hairpin hybridization following 
aptamer–protein binding. Then, the cascade signal amplification 
of CHA and HCR is successively performed. Finally, the G-quad-
ruplex formed in the long duplex transmits the corresponding 
fluorescent signals.[112] Target-induced joint binding-initiating 
is achieved with CHA substrates containing aptamer sequence. 
The fluorophore labeled hairpins including the aptamer domain 
are modified on Au NPs to quench the fluorescence. Once the 
hairpins bind to thrombin, the structure is transformed into 
a single strand. The newly formed single strand then binds to 
another hairpin and releases thrombin. The above processes pro-
gress through cycles. The fluorescence is recovered because the 
massive fluorophores are far from the Au NPs.[31]
Beyond the abovementioned protein detection methods, 
avidin can be used as a CHA mediator with biotin. Avidin binds 
to biotin with extremely high affinity, and biotin can be easily 
conjugated to proteins or nucleic acids. Li et al. proposed an 
avidin detection system including partially complementary 
DNA duplex OT, single-stranded DNA C, and a pair of DNA 
hairpins as shown in Figure 5C.[113] Biotin is linked at the ends 
of O and C. Avidin strongly interacts with biotin, bringing C 
and OT into proximity, which accelerates the strand displace-
ment between OT and C. Therefore, CHA is initiated by O for 
signal amplification. Meanwhile, avidin–biotin protects single-
stranded nucleic acids from hydrolysis by Exo I. Liu et al. used 
this characteristic for developing a protein assay. Biotin is pre-
pared at the end of a single-stranded nucleic acid that can be 
digested by Exo I without a following reaction. In the presence 
of avidin, the strand stably exists and triggers a subsequent 
CHA reaction for signal amplification (Figure 5D).[87]
Small 2019, 15, 1902989
Figure 5. Protein and enzyme biosensors based on CHA. A) Ab-mediated protein biosensor.[105] B) Aptamer-mediated protein biosensor.[111] C) Biotin 
mediated avidin biosensor.[113] D) Avidin–biotin protection mediated avidin biosensor.[87] E) Enzyme activity detection based on CHA.[115] F) Telomerase 
assay based on CHA.[28]
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3.2.2. Detection of Enzyme Activity
Enzymes are unique proteins present in body fluids, cells, and 
tissues. Enzymes enable the catalyzation of substrates with 
high specificity in many biological processes. Abnormal expres-
sion of enzymes results in dysfunction, and accurate detec-
tion of enzymes is important for the treatment of diseases. 
CHA based enzyme biosensors function in a different manner 
with other biomarkers. Generally, enzymes act on specific sub-
strates, yielding single-stranded DNA to unfold the hairpins 
of the CHA system. Most enzymes hydrolyze the probes to 
release the initiators.[114] A CHA based enzyme activity assay is 
presented in Figure 5E.[115] In the absence of RNase H, RNA/
DNA duplex probes are intact, and the partially complemen-
tary hairpins are stable in solution. The RNA in the RNA/DNA 
duplex is prone to hydrolysis by RNase H. Hence, RNase H 
catalyzes the digestion of the RNA and the release of the DNA. 
Thereby, the hairpins are successively opened to form duplexes, 
and signals accumulate. These strategies enable the analysis of 
enzyme activity at mU mL−1 concentrations. Telomerase elon-
gates tandem 6 bp DNA repeats (TTAGGG) at the ends of spe-
cific telomerase substrates (TS). Telomerase can hybridize with 
probes resulting in displacement or migration following the 
free initiator. As shown in Figure 5F, the CHA based telom-
erase assay is simple and can be visualized.[28] TS primers are 
successively added with repeated sequences. Then, the hairpin 
probes containing the initiator domain in the stem are unfolded 
by the repeat sequence. The CHA reaction is triggered and the 
G-quadruplexes at the ends of the products produce signals. 
CHA based telomerase assays exhibit high specificity and sensi-
tivity, and work well for intracellular telomerase analysis.
3.3. Detection of Small Molecules and Metal Ions
Nucleic acids and proteins are the most common biomarkers. 
In addition to these two kinds of biomarkers, small molecules 
such as ATP, adenosine, and antibiotic participate in various 
biological processes. Metal ions are closely associated with 
human health and the environmental security. The development 
of simple and reliable detection methods for these molecules is 
important. However, these metal ions cannot activate the CHA 
reaction. Because of the functional nucleic acids, many strate-
gies based on CHA have been explored for these molecules.
Small molecules with simple structures fail to directly trans-
duce targets into a signal output. The appearance of aptamers 
broadens the analysis techniques for small molecules. Usually, 
the initiator DNA is protected in probes involving the aptamer 
domain. The introduction of the target brings a free initiator. 
The most typical CHA based aptasensor for small molecules is 
presented in Figure 6A.[116] The initiator domain and aptamer 
domain are predesigned in the probe. The aptamer domain 
is released along with the conjugation between aptamer and 
target. With varied signal output platforms, the system signal 
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Figure 6. Small molecule and metal ion biosensors based on CHA. A) CHA-based aptasensor for small molecule detection.[116] B) DNAzymes assisted 
by target metal ions mediated metal ion detection.[124] C) Metallo-toehold induced Hg2+ detection.[125] D) CuAAC induced Cu2+ detection.[127]
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can be delivered through indicators[32] or coupled with another 
signal amplification method recovering DNAzyme,[117,118] 
NPs,[119] and HCR-analogous isothermal amplification.[120,121] 
Li et al. extended the probe containing aptamers and metal 
ion-dependent DNAzyme for small molecules.[122] DNAzyme is 
generated with recognition between the aptamer and target. The 
target-aptamer-DNAzyme can circularly catalyze the substrate to 
produce accumulation of initiator DNA. Then, the CHA reaction 
proceeds. This strategy detects ATP as low as 0.6 × 10−9 m and 
well discriminates ATP from analogous molecules.
Metal ions also perform other roles. In terms of their roles as 
coenzymes, toehold assistants and mediums of click chemistry, 
assays for metal ions can be classified into three classes. Some 
DNAzymes function with metal ions, such as Pb2+, Cu2+, Zn2+, 
and Na+ for cleaving the phosphodiester backbone at ribonucleo-
tide sites on substrate chains.[123] Probes are arranged along the 
DNAzyme strand and the substrate chain containing initiator 
domain (Figure 6B).[124] The CHA reaction is activated because 
initiator DNA is released in the presence of metal ions. Through 
this strategy, different metal ions can be analyzed simultaneously.
Hg2+ can produce a bridge structure (thymine-Hg2+-thymine) 
in the toehold region as a metallo-toehold. Thus, the rates of 
the DNA displacement reaction are controlled by Hg2+. This 
property of Hg2+ is brought into full play for Hg2+ detection. 
Li et al. designed a reliable strategy for Hg2+ based on the 
metallo-toehold initiated branched CHA reaction.[125] The 
system functions using the initiator probe, substrate probe and 
hairpins, as shown in Figure 6C. When Hg2+ is introduced, the 
initiator probe forms thymine-thymine mismatched base pairs 
with H1 and activates the follow-up DNA hybridization and 
displacement. The split DNAzymes are closed alongside the 
generation of branched DNA junctions, and catalyze the sub-
strate hairpins to generate output signals.
Cu+-catalyzed azide-alkyne cycloaddition (CuAAC) is a 
typical example of click chemistry with high specificity and effi-
ciency. Therefore, scientists have shown interest in developing 
a more practical assay for Cu2+. Cu2+ can be reduced to Cu+ 
triggering CuAAC.[126] When azide and alkyne are modified 
onto DNA probes, CuAAC leads to structure switching. In this 
way, the initiator for CHA emerges. As shown in Figure 6D, 
CuAAC stimulates the activity of DNAzyme and the initiator is 
gained. The initiator circularly works toward the accumulation 
of CHA products and signals. This strategy opens the way for 
expanding Cu2+ assays.[127]
3.4. Detection of Cancer Cells
Cancer cells, derived from primary tumors, are significant and 
valuable for early cancer diagnosis and the discovery of minimal 
residual diseases. Cancer cells are also attractive circulating 
tumor markers. Because of their low concentrations and com-
plicated components, developing accurate and simple cancer 
cell assays remains challenging. Specific constituents of cancer 
cells, such as DNA, mRNA, miRNA, and proteins, can provide 
information on cancer cells. Therefore, the amounts of cancer 
cells can be measured using the strategies described above. At 
the same time, cancer cells are intact biomarkers. The existence 
of cancer cells in blood or tissue specimens is the most direct 
evidence for cancer diseases. Hence, the quantification of intact 
cancer cells is important for practical applications. Researchers 
have found that aptamers and Abs can recognize and capture 
cancer cells with high specificity and strong affinity.
In previous work, we have constructed a CHA based 
cytosensor with an aptamer (Figure 7A). The system is accessible 
with the use of a probe and CHA hairpins. Mucin 1 is an over-
expressed transmembrane protein in A549 lung cancer cells. 
Once mucin 1 binds to the aptamer strand of the probe, the ini-
tiator domain is exposed. Various CHA systems and analytical 
platforms can be applied. CHA based aptasensors for cancer 
cells exhibit high sensitivity down to 10 cell mL−1 and satisfac-
tory selectivity between the target and interferent cells.[29] These 
cytosensors rely heavily on the development of aptamers.
A CHA based cytosensor with Ab recognition elements has 
been developed for SK-BR-3 breast cancer cells overexpressing 
HER-2 (Figure 7B).[128] In this system, the two single-stranded 
probes with split initiator sequences are partially complemen-
tary. HER-2-specific Abs are separately conjugated to the two 
probes through streptavidin–biotin interactions. The two Abs 
recognize the target cancer cells bringing the two probes into 
proximity. Then, the two probes hybridize, providing an initi-
ator domain for CHA. This kind of cytosensor can distinguish 
targets from the isotype control.
3.5. Intracellular Analysis
Monitoring the markers in living cells provides first-hand and 
dynamic information, which contributes to disease surveillance 
and biological research. CHA, a nonenzymatic and isothermal 
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Figure 7. Cancer cell biosensors based on CHA. A) CHA-based cytosensor with aptamer.[29] B) CHA-based cytosensor with Ab.[128]
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amplification technique, is valuable for biomarker analysis with 
high efficacy and promising versatility. The intracellular com-
plexity and interference of endogenous detection still remain 
some problems. Transport and enzyme degradation are the 
most prominent problems. Great effort has been made to 
develop useful intracellular detection methods based on 
CHA.
The intracellular amplification circuits are almost the same 
as those used in fluorescent strategies in vitro and have been 
verified before intracellular determination. Biomarkers including 
mRNA, miRNA, metal ions, and telomerase, have been imaged 
with CHA based strategies. Scientists have employed modified 
nucleic acids[129] or NPs[130] to protect the system components.
Regarding delivery, four methods have been used for CHA 
systems: endocytosis, transfection reagent induced, nanomate-
rials mediated, and genetically encoded. Endocytosis is the most 
direct but risky method, as nucleic acids are prone to being 
digested by nucleases. The CHA system has been transported 
into living cells through endocytosis for miRNA-21 imaging.[131] 
Studies indicate that self-assembled DNA nanowires have cell 
membrane permeability. Based on this finding, Wei et al. pro-
posed a nanowire bearing CHA substrates (Figure 8A). The 
DNA nanowire serves as a carrier. Then, cells overexpressing 
miRNA-21 are turned “on” with CHA amplification. The 
strategy skillfully delivers the CHA system without noxious 
transfection reagents and provides a satisfactory platform for 
biomarker imaging in living cells.[43]
In general, transfection reagents such as liposomes, cationic 
polypeptide G8, and H400 interact with nucleic acids, forming 
complexes and escaping nucleases. This is the most frequently 
used method for the delivery of CHA transcytosis. As shown 
in Figure 8B, the Na+ detection system based on CHA-DNA-
zyme is successfully transported into living cells with the help 
of cationic polypeptide G8.[132] The strategy not only accurately 
quantifies endogenous Na+, but also dynamically monitors 
the change of Na+. Additionally, this work provides a general 
method for intracellular biomarker detection. As shown in 
Figure 8C, GO is the carrier of two sets of CHA substrates, 
moving them toward the cytoplasm.[26] Then, the CHA reaction 
is activated by the targets to amplify the signals. The detection 
limit is low to picomolar level, and strong fluorescence can be 
detected. This strategy may provide a new method by which to 
trace intracellular biomarkers.
In recent years, nanomaterials including Au NP, graphene 
oxide (GO) and carbon nitride nanosheet have been extensively 
used as biosensors. Nano materials possess good biocom-
patibility, little toxicity, and strong adsorption. These unique 
characteristics make nano materials suitable for intracellular 
biomarker imaging.
Karunanayake Mudiyanselage et al. not only validated CHA 
with RNA molecules, but also imaged the endogenous target 
RNA through genetically encoded and transcribed RNA CHA 
(Figure 8D).[45] The fluorescent RNA molecules Broccoli, which 
can activate the fluorescence of small molecule dyes, has been 
Small 2019, 15, 1902989
Figure 8. CHA based biomarker imaging in living cells. The CHA system is transported into cells through A) endocytosis,[43] B) transfection agent,[132] 
C) nano materials,[26] and D) genetically encoded and transcribed RNA CHA.[45]
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divided into two parts at the two hairpins separately. First, the 
researchers designed and constructed the RNA assay in vitro. 
The strategy presents high sensitivity at concentrations as low 
as 0.5 × 10−9 m and an efficient and fast response to the target 
RNA. Then, the two hairpins are cloned into a dual expression 
vector, and the target sequence is cloned into another vector. 
The vectors are transformed into cells and induced for 2 h. 
Finally, the fluorescence signal is observed using a confocal 
fluorescence microscope. This strategy provided a brand-new 
method for cellular RNA determination.
4. Conclusions and Perspectives
In the past decade, tremendous achievements have been made 
regarding CHA based bioanalysis from origin to widespread 
application. Dozens of expanded CHA systems have been pro-
grammed with several nucleic acid strands. Through these efforts, 
the amplification efficacy was improved, and the background 
signal was controlled. CHA circuits function in the absence of 
enzymes under isothermal conditions, showing desirable ampli-
fication efficacy. For this reason, CHA circuits have been adapted 
for the specific and sensitive detection of various targets covering 
proteins, DNA, miRNA, mRNA, metal ions, small molecules, and 
cancer cells in vitro or in living cells. Because of its versatility, the 
CHA reaction can be coupled with NPs, other isothermal ampli-
fication techniques, and DNAzymes, achieving cascade signal 
amplification. Various signal outputs can be used for CHA based 
biosensors. CHA circuits with unique properties provide diverse 
biosensors with promising performance and good convenience.
To further extend the applications and make CHA suitable for 
practice, more efforts need to be devoted to the following points. 
1) Various CHA systems possess their own advantages and work 
in different strategies. We may continue exploring the mecha-
nism of CHA and design more interesting CHA systems to make 
CHA circuits more widely accessible. 2) Except for nucleic acid 
targets, most biomarkers require specific recognition and trans-
ducer elements. Hence, studies of specific, simple, and stable 
recognition elements (such as aptamers and Abs) are warranted. 
Thus, other emerging markers (for example, exosomes and rare 
cells) will be able to be easily analyzed in vitro or in living cells 
based on CHA. 3) CHA circuits, with excellent biocompatibility 
and perfect signal performance, are prone to being combined 
with novel nanomaterials (such as aggregation-induced emis-
sion molecules) and newly molecular biotechnology. For more 
novel and efficient CHA based assays, more contributions are 
needed to make full use of these materials. 4) The majority of 
biomarkers exist in blood or tissue in trace amounts. Absolute 
quantification technologies play an important role in practical 
applications and single-cell determination. CHA circuits, with 
the attractive advantages of high efficiency and constant tempera-
ture, are desirable choice for absolute quantification technologies 
(such as droplet microfluidics and nanoflow cytometry).
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